Patent · US Active

RNA for use in the treatment of ligament or tendon lesions

US11065346B2 · kind B2 · utility

0Cited by

1References

9Claims

0Family size

Assignee

ethris GmbH · DE

Inventors

Günther Hasenpusch · Hersbruck, DE
Carsten Rudolph · Krailling, DE

Key dates

Filing date	Apr 29, 2019
Grant date	Jul 20, 2021
Priority date	—
Expiry date	Apr 29, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P19/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described is a liquid composition containing naked RNA, such as mRNA encoding a polypeptide, for use in the treatment or prevention of ligament or tendon lesions as well as a method for treating ligament or tendon lesions comprising the administration of a liquid composition containing naked RNA, such as mRNA encoding a polypeptide, which is beneficial in the process of healing the ligament or tendon lesions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.